Study of IDO Inhibitor in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Metastatic Pancreatic Cancer
Lumos Pharma
Lumos Pharma
Eli Lilly and Company
NanOlogy, LLC
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Gilead Sciences
National Cancer Institute (NCI)
City of Hope Medical Center
Radiation Therapy Oncology Group
Rutgers, The State University of New Jersey